FindTrial
Sign In

LMY-922

BIOLOGICAL2 trials

Sponsors

Luminary Therapeutics

Conditions

Chronic Lymphocytic LeukemiaDermatomyositis (DM)Hairy Cell LeukemiaMultiple MyelomaNon-Hodgkin LymphomaRheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Systemic Sclerosis (SSc)

Phase 1

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
Not yet recruitingNCT07679919
Luminary TherapeuticsChronic Lymphocytic Leukemia, Hairy Cell Leukemia, Multiple Myeloma +1
Start: 2026-09-01End: 2029-04-01Target: 27Updated: 2026-07-01
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
Not yet recruitingNCT07729995
Luminary TherapeuticsDermatomyositis (DM), Rheumatoid Arthritis (RA), Systemic Lupus Erthematosus (SLE) +1
Start: 2026-10-01End: 2030-03-01Target: 94Updated: 2026-07-28